(Q33784185)

29 July 2017

title

Long-term complications with prostate implants: iodine-125 vs. palladium-103. (English)

1 reference

29 July 2017

Peschel RE

1

1 reference

29 July 2017

Chen Z

series ordinal

2

1 reference

29 July 2017

Roberts K

series ordinal

3

1 reference

29 July 2017

Nath R

series ordinal

4

1 reference

29 July 2017

publication date

1 January 1999

1 reference

Radiation Oncology Investigations

29 July 2017

published in

1 reference

29 July 2017

volume

7

1 reference

29 July 2017

issue

5

1 reference

29 July 2017

page(s)

278-288

1 reference

Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer.

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A5%3C278%3A%3AAID-ROI3%3E3.0.CO%3B2-3

Outpatient ultrasound-guided palladium 103 brachytherapy for localized adenocarcinoma of the prostate: a preliminary report of 434 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A5%3C278%3A%3AAID-ROI3%3E3.0.CO%3B2-3

The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A5%3C278%3A%3AAID-ROI3%3E3.0.CO%3B2-3

Radiobiological assessment of permanent implants using tumour repopulation factors in the linear-quadratic model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A5%3C278%3A%3AAID-ROI3%3E3.0.CO%3B2-3

Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. American Association of Physicists in Medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A5%3C278%3A%3AAID-ROI3%3E3.0.CO%3B2-3

Report of the ad hoc committee of the AAPM radiation therapy committee on 125I sealed source dosimetry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A5%3C278%3A%3AAID-ROI3%3E3.0.CO%3B2-3

The linear-quadratic formula and progress in fractionated radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A5%3C278%3A%3AAID-ROI3%3E3.0.CO%3B2-3

Clinical course of rectal bleeding following I-125 prostate brachytherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A5%3C278%3A%3AAID-ROI3%3E3.0.CO%3B2-3

Prostate specific antigen based disease control following ultrasound guided 125iodine implantation for stage T1/T2 prostatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A5%3C278%3A%3AAID-ROI3%3E3.0.CO%3B2-3

Short-term freedom from disease progression after I-125 prostate implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A5%3C278%3A%3AAID-ROI3%3E3.0.CO%3B2-3

103Pd brachytherapy and external beam irradiation for clinically localized, high-risk prostatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A5%3C278%3A%3AAID-ROI3%3E3.0.CO%3B2-3

Biochemical disease-free survival following 125I prostate implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A5%3C278%3A%3AAID-ROI3%3E3.0.CO%3B2-3

Transperineal palladium 103 prostate brachytherapy: analysis of morbidity and seed migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A5%3C278%3A%3AAID-ROI3%3E3.0.CO%3B2-3

Tumor cure studies on the rat sarcoma BA1112 using continuous low-dose-rate radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A5%3C278%3A%3AAID-ROI3%3E3.0.CO%3B2-3

Permanent implants using Au-198, Pd-103 and I-125: radiobiological considerations based on the linear quadratic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A5%3C278%3A%3AAID-ROI3%3E3.0.CO%3B2-3

Clinical impact of implementing the recommendations of AAPM Task Group 43 on permanent prostate brachytherapy using 125I. American Association of Physicists in Medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A5%3C278%3A%3AAID-ROI3%3E3.0.CO%3B2-3

Dose fractionation, dose rate and iso-effect relationships for normal tissue responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A5%3C278%3A%3AAID-ROI3%3E3.0.CO%3B2-3

Changes in early and late radiation responses with altered dose fractionation: implications for dose-survival relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A5%3C278%3A%3AAID-ROI3%3E3.0.CO%3B2-3

Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A5%3C278%3A%3AAID-ROI3%3E3.0.CO%3B2-3

Maximum utilization of the life table method in analyzing survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A5%3C278%3A%3AAID-ROI3%3E3.0.CO%3B2-3

The PSA nadir that indicates potential cure after radiotherapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A5%3C278%3A%3AAID-ROI3%3E3.0.CO%3B2-3

10.1002/(SICI)1520-6823(1999)7:5<278::AID-ROI3>3.0.CO;2-3

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference